CD8A and glioma: In all the in vivo experimental models, p32-CAR T cells induced the regression of GBM growth, and it is important to highlight that this effect was assessed on endogenous levels of p32 expression, no overexpression or ex vivo modifications were performed to the transplanted glioma cells.